Respiratory syncytial virus: vaccines
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 29, 1993
Issued Date -
N/A
app pub date -
Sep 20, 1988
filing date -
Sep 29, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Polypeptides, nucleotides, and compositions useful for preparing diagnostic reagents for and vaccines against human Respiratory Syncytial Virus are disclosed. The polypeptides include short polypeptides which are related to a neutralizing and fusion epitope of the Respiratory Syncytial Virus fusion protein or a neutralizing epitope of the G protein.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully